<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04847401</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-04-03</org_study_id>
    <nct_id>NCT04847401</nct_id>
  </id_info>
  <brief_title>the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome</brief_title>
  <official_title>Evaluation of the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluating any possible relationship between irritable bowel syndrome occurrence and&#xD;
      Helicobacter pylori infection&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 25, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>number of irritable bowel syndrome patients who had H.pylori infection</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>H.pylori stool antigen kits</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>patients with Irritable Bowel Syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>normal</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>H. pylori stool antigen</intervention_name>
    <description>using H. pylori antigen kits in stool</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        outpatient clinic patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients will be selected according to Rome IV criteria for the diagnosis of IBS,&#xD;
             which include:&#xD;
&#xD;
        Recurrent abdominal pain at least 1 day/week in the last 3 months, with two or more of the&#xD;
        following criteria:&#xD;
&#xD;
          -  Related to defecation&#xD;
&#xD;
          -  Associated with a change in frequency of stool&#xD;
&#xD;
          -  Associated with a change in form of stool. Criteria achieved for the last 3 months&#xD;
             with symptom onset at least 6 months before diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Rectal bleeding&#xD;
&#xD;
               -  Anemia&#xD;
&#xD;
               -  Weight loss&#xD;
&#xD;
               -  Onset after 50 years of age&#xD;
&#xD;
               -  Recent antibiotic use&#xD;
&#xD;
               -  Abnormal abdominal examination (organomegaly, lump)&#xD;
&#xD;
               -  Family history of colorectal cancer.&#xD;
&#xD;
               -  Family history of inflammatory bowel disease, or celiac disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Reham Mohy Kamel, MBBCh</last_name>
    <phone>01274648573</phone>
    <email>reham.amin@med.sohag.edu.eg</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Reham Mohy El-Din Kamel</investigator_full_name>
    <investigator_title>Resident doctor</investigator_title>
  </responsible_party>
  <keyword>Helicobacter Pylori</keyword>
  <keyword>Irritable Bowel Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

